Pediatrics researchers at The Children?s Hospital of Philadelphia and McGill University in Montreal have identified a gene variant that raises a child?s risk for type 1 diabetes, formerly called juvenile diabetes.
Bayer Healthcare and FDA notified healthcare professionals and consumers of a Class 1 Recall of Bayer Ascensia Contour Blood Glucose Monitoring System, Product 7152A.
Selenium, an antioxidant included in multivitamin tablets thought to have a possible protective effect against the development of type 2 diabetes, may actually increase the risk of developing the disease, an analysis by researchers at the University at Buffalo has shown.
Eli Lilly and Company (NYSE: LLY) and Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) welcomed the recent decision by the Scottish Medicines Consortium (SMC) on the use of BYETTA(R) (exenatide) in Scotland.
Far fewer rheumatoid arthritis patients treated with the drug hydroxychloroquine (HCQ) went on to develop diabetes compared to those who never took the drug, according to a 20-plus-year University of Pittsburgh School of Medicine-led study reported today in the Journal of the American Medical Association.
Most Americans fail to get the calcium and vitamin D they need, but this shortfall could be affecting more than their bones. It may, at least in part, be one reason behind the epidemic of type 2 diabetes, suggests new research conducted at Tufts University.
A new analysis of data from a large national study found that people who took a 200 microgram selenium supplement each day for almost eight years had an increased risk of developing type 2 diabetes than those who took a placebo or dummy pill.
Bigger waistlines are a growing problem in Australia and are the focus of this year?s National Diabetes Week, running July 8-14.
Patients with type 2 diabetes may soon be able to control their glucose and their cholesterol levels with a single drug, according to a study led by Vivian A. Fonseca, professor of medicine and pharmacology at Tulane University School of Medicine and chief of the Tulane University Health Sciences Center Diabetes Program.
A new Wesley Research Institute project aims to make it much easier for people to manager their type 2 diabetes by using community pharmacists.